Literature DB >> 33708089

Primary Cutaneous Cryptococcosis due to Cryptococcus neoformans in an Immunocompetent Host Treated with Itraconazole and Drainage: Case Report and Review of the Literature.

Elizabeth Gaviria Morales1, Marco Guidi2,3, Tomas Peterka2,4, Andrea Rabufetti1, Roland Blum5, Carlo Mainetti1.   

Abstract

Cryptococcus neoformans is an opportunistic germ, usually causing infections in immunocompromised patients. The main sources of infection with C. neoformans are excrement from birds, decomposing wood, fruit, and vegetables. Primary cutaneous cryptococcosis (PCC) is a clinical entity, differing from secondary cutaneous cryptococcosis and systematic infection. We report the case of an immunocompetent 60-year-old woman with PCC due to C. neoformans in her right thumb. She reported an accidental injury caused by a rose thorn while she was gardening. Clinical examination showed the presence of an erythematous ulcerated nodule with elevated borders, suppuration, and central necrosis. Skin histology examination showed cutaneous and subcutaneous fibrinoid necrosis with bleeding, abscess, neutrophil-rich cellular infiltration, and the presence of PAS-, Grocott- and mucin-positive spores. The mycological culture showed milky and creamy colonies of C. neoformans after 3 days. As there was no previous history of pulmonary cryptococcosis, we diagnosed PPC. We treated the patient surgically with accurate debridement of nonvital tissues in the right thumb. In addition, we started itraconazole treatment 100 mg twice daily for 6 months, which led to rapid clinical improvement without relapse. PCC is a rare infection that can present with quite unspecific clinical pictures including acneiform lesions, purpura, vesicles, nodules, abscesses, ulcers, granulomas, pustules, draining sinuses, and cellulitis. Prolonged systemic antifungal therapy is necessary in order to get a healing result without relapse. We summarize all the cases of PCC in immunocompetent patients published so far in the literature.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Cryptococcus neoformans; Immunocompetent host; Itraconazole; Primary cutaneous cryptococcosis; Ulcer

Year:  2021        PMID: 33708089      PMCID: PMC7923711          DOI: 10.1159/000512289

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Cryptococcus neoformans is an opportunistic germ, usually causing infections in immunocompromised patients. The main sources of infection with C. neoformans are excrements from birds, decomposing wood, fruit, and vegetables. Primary cutaneous cryptococcosis (PCC) is a clinical entity, differing from secondary cutaneous cryptococcosis and systemic infection [1, 2, 3, 4]. We present the case of an immunocompetent woman with PCC due to C. neoformans in her right thumb, together with a review of the current literature.

Case Report

A 60-year-old woman presented to our department with a 4-day-old swelling and erythema around the right thumb, having already been treated with cefuroxime for 3 days by her general practitioner without any improvement. She reported an accidental injury 5 days previously caused by a rose thorn while she was gardening. The patient was in good health and had not taken any immunosuppressives or other drugs. There was no history of any contact with avian excretions, pigeons, or other animals, and she denied recent travelling. On dermatological examination, we found an erythematous ulcerated nodule with elevated borders, suppuration, and central necrosis (Fig. 1a). There was no regional lymphadenopathy and no other skin involvement. Routine blood examination, a total lymphocyte count, and blood immunoglobulins were normal. The C-reactive protein level was 55 mg/L, while the erythrocyte sedimentation rate was 77 mm/h. HIV and hepatitis B and C serology results were negative. X-rays of the chest and the right thumb were also normal. At first, we suspected a bacterial or herpetic infection, but the lesion swab cultures for bacteria and the PCR examination for Mycobacterium as well as herpes simplex virus were also negative. We performed a biopsy for histological examination from skin lesion fragments after surgical debridement, removing necrotic tissue from the right thumb (Fig. 1b). The histology picture showed cutaneous and subcutaneous fibrinoid necrosis with bleeding, an abscess forming, neutrophil-rich cellular infiltration, and the presence of multiple PAS-, colloid iron- and mucin-positive spores (Fig. 2).
Fig. 1

a Initial cutaneous necrosis of the right thumb of a 60-year-old woman. b Two days after hospitalization and after surgical debridement of the necrotic parts of the right thumb.

Fig. 2

a Histology of the surgical debridement of the right thumb. Fibrinoid-necrotic, subcutaneous adipose tissue with hemorrhage and evidence of mucin-positive spores. Colloidal iron. ×200. b The mucin-positive spores had a halo or a slime capsule. Colloidal iron. ×400.

A swab sample from the lesion was inoculated on tubes with slide Sabouraud chloramphenicol and BBLTM MycoselTM agar and incubated at 30 and 35°C. On day 3, milky and creamy colonies of C. neoformans started to grow on the Mycosel agar at 30°C. Then, colonies were transferred to an agar plate (Sabouraud chloramphenicol agar and ChromID Candida; bioMérieux) and incubated at the same temperatures. Microscopical examination showed globose-to-ovoid, budding, yeast-like cells. Identification of C. neoformans was possible with matrix-assisted laser desorption ionization-time of flight mass spectrometry [5]. We diagnosed PPC in an immunocompetent patient. For antifungal susceptibility assessment, we used the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines [6]. The antifungals tested were amphotericin (0.5 mg/L), ketoconazole (0.64 mg/L), itraconazole (0.121 mg/L), 5-fluorocytosine (1 mg/L), voriconazole (0.064 mg/L), and fluconazole (4 mg/L). In addition to the debridement, we performed two lateral incisions in a sterile area next to the medial and lateral perionychium to drain collections. The necrotic epidermis of the fingertip was completely detached in its superficial layer. After the surgical debridement, the patient needed periodic dressing. Complementary to surgical therapy, we started treatment with itraconazole 100 mg/12 h for 6 months, with rapid clinical improvement and without relapse to infection during the 6-month follow-up after the systemic antifungal therapy (Fig. 3).
Fig. 3

Right thumb after 6 months of itraconazole treatment 100 mg twice daily. Note the loss of substance to the fingertip.

Discussion

The genus Cryptococcus comprises the two clinically relevant species C. neoformans and C. gattii among few other species. Whilst C. neoformans is mainly observed in patients with immunodeficiency and rarely in immunocompetent patients, C. gattii is found in immunocompetent patients in endemic areas [4, 5]. The main sources of infection with C. neoformans are excrements from pigeons or other birds, as well as decomposing wood, fruit, and vegetables [3]. C. gattii is not present in birds' feces, but it inhabits a variety of arboreal species, including several types of eucalyptus tree [1]. PCC is a separate clinical entity distinct from secondary cutaneous cryptococcosis, the latter of which mainly occurs in patients with lung cryptococcosis and systemic infection. Generally, secondary cutaneous cryptococcosis infection occurs in immunocompromised hosts and rarely in immunocompetent hosts [7, 8]. PCC is a rare infection that can present with quite unspecific clinical pictures, including acneiform lesions, purpura, vesicles, nodules, abscesses, ulcers, granulomas, pustules, draining sinuses, and cellulitis [9, 10]. For a long time, the existence of PCC as a clinical entity had been in doubt. In the year 1972, Noble and Fajardo [10] proposed three diagnostic criteria for PCC (Table 1). We recorded the features of both our case and the 21 additional cases of PCC in immunocompetent patients due to C. neoformans in the last 20 years [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27]. We excluded cases of PCC due to C. gattii, which is well known to be a cause of infection of immunocompetent patients in endemic areas [1]. Our case and the other cases reviewed fulfill all diagnostic criteria by Noble and Fajardo (Table 1).
Table 1

Diagnostic clinical criteria for primary cutaneous cryptococcosis according to Noble and Fajardo [10]

1Absence of infection in other organs
2Cryptococcus neoformans must be isolated from skin
3Absence of extracutaneous infection within 4 weeks after the primary cutaneous cryptococcosis diagnosis
Parameters such as year of diagnosis, age, gender, predisposing factors, clinical manifestation(s), treatment prescribed, and outcome are reported separately (Table 2). The male sex was more affected (17/22 cases). The patients' ages ranged from 10 to 81 years (mean 60.13). The most frequent site of infection was the forearm (9/22), followed by the hand and fingers (6/22). Clinical manifestations consisted of nodules, sometimes ulcerated (9/22), infiltrative lesions (4/22), plaques (3/22), papules (1/22), cellulitis (2/22), granulomata (1/22), erythema with edema (1/22), and lipoma-like swelling (1/22) (Table 2). Only in 10 of the 22 patients was there a history of trauma prior to infection. Nine of the 22 cases reported contact with avian excreta. In 8 of the 22 cases, the source of infection was totally unknown.
Table 2

Demographic and clinical data on immunocompetent patients with primary cutaneous cryptococcosis

Case No.Study [Ref.]Year of reportAge, years/genderPredisposing factor(s)Clinical manifestation(s)Treatment (drug/daily dose/duration of treatment)Outcome
1Revenga et al. [2]200246/MTraumaCellulitis in third right fingerITZ 200 mg/d, 10 months + surgical excision + ITZ 200 mg/d 1 monthCured

2Al-Marzooq et al. [13]200543/MUnknownNodules on forehead and in lumbar regionUnknownCured

3Xiujiao and Ai'e [14]200535/MUnknownPainless nodules on thighITZ 400 mg/d, 3 days, then FCZ 200 mg/d for 14 days, then ITZ 200 mg/d for 2 monthsCured

4Kumar et al. [15]200540/MUnknownPainless subcutaneous lipoma-like swelling of abdominal flankFCZ (dosage and time not reported)Cured

5Yuge et al. [16]200675/FUnknownErythematous plaque on forearmFCZ 400 mg/d, 3 months, then AMB 50 mg, 3 times a week for 15 weeks, then ITZ 200 mg/d for 6 monthsCured

6Allegue et al. [17]200771/MUnknownPainful erythematous and edematous, whitlow-like skin of right thumbFCZ 400 mg/d, 1 month, then 200 mg/d, 2 monthsCured

7Pau et al. [1]201058/MTraumaGrowing nodule from hand to forearmITZ 200 mg/d for 4 monthsCured

8Werchniak and Baughman [18]201081/MTrauma and contact with avian ex-cretaAsymptomatic nodule on forearmITZ 200 mg/d for 3 monthsCured

9Nasser et al. [19]201167/MTrauma and contact with avian ex-cretaItching nodule, ulceration on forearmFCZ 450 mg/d for 40 daysCured

10Spiliopoulou et al. [20]201258/MUnknownGranulomatous lesion with ulcer on handFCZ 200 mg/d, 2 weeksCured

11Spiliopoulou et al. [20]201267/FContact with avian ex-cretaPainful cellulitis with ulceration on fingerSurgery and 2 weeks of 200 mg/d FCZ, then 2 weeks of FCZ 100 mg/dCured

12Marques et al. [21]201272/MTrauma and contact with avian ex-cretaInfiltrative or tumoral-aspect lesion of forearmITZ 200 mg/d for 3 monthsCured

13Marques et al. [21]201279/MTrauma and contact with avian ex-cretaInfiltrative or tumoral-aspect lesion of arm and forearmFCZ 300 mg/d for 2 monthsCured

14Marques et al. [21]201270/MUnknownInfiltrative or tumoral-aspect lesion of forearmITZ 100 mg/d for 3 monthsCured

15Marques et al. [21]201275/FTrauma and contact with avian ex-cretaInfiltrative or tumoral-aspect lesion of forearmFCZ 400 mg/d, 3 months, + AMB total 2,250 mgCured

16Narváez-Moreno et al. [22]201266/MContact with avian ex-cretaAsymptomatic nodules, ulcer and molluscum-like papules on penisITZ 400 mg/d for 3 monthsCured

17Jackson and Herring [23]201573/MTraumaMultiple nodules and ulcers in sporotrichoid pattern on right third and fourth digits and distal forearmITZ 200 mg/d for 5 months, then ITZ 100 mg/d for 1 monthCured

18Hyde et al. [24]201610/FUnknownUlcerated nodule on right footNo treatmentCured

19Henderson and Dreyer [25]201869/MTraumaUlcer, bullous lesions, and edema on right armFCZ 400 mg/d for 1 yearCured

20Twede and Peters [26]201828/FTrauma and contact with avian ex-cretaAnnular erythematous plaque lesions on shins and calvesFCZ 200 mg twice daily for 6 monthsCured

21Beatson et al. [27]201980/MPigeon breederUlcerated plaques on left cheek and right earFCZ 200 mg/d for 2 monthsCured

22Present case202160/FTraumaErythematous ulcered nodule, suppuration, and central necrosis of right thumbSurgery, then ITZ 200 mg/d daily for 6 monthsCured

M, male; F, female; d, day; AMB, amphotericin B; FCZ, fluconazole; ITZ, itraconazole.

Concerning the kind of inflammation, it should be kept in mind that the different well-known patterns or stages of cutaneous cryptococcosis (suppurative, gelatinous, and granulomatous) are reflecting the dynamic process and ability of the hosts' immune system to get rid of the infectious agents, which usually takes a few years. As PCC is a rare event in immunocompetent patients, unlike in systemic disease, treatment in this setting is not well defined. Nonetheless, itraconazole was effective in curing the lesions in 10/22 cases; 8 of these cases were treated with itraconazole only, whereas in 1 case itraconazole was the final treatment after switching from fluconazole (case 3) and in 1 case itraconazole was the final treatment after previous treatment with fluconazole and amphotericin (case 5). Fluconazole alone was administered in 11/22 cases, but healing could only be achieved in 9 of these cases; in the remaining 2 cases (cases 3 and 5), it was necessary to switch to itraconazole and in 1 case healing was achieved after combined treatment with fluconazole and amphotericin (case 15). The range of itraconazole dosage was 100–400 mg/day for a duration of 3–6 months. The range of fluconazole dosage was 200–800 mg/day for a duration of 2 weeks to 1 year. Two of the 22 cases reviewed, including ours, had also undergone surgical debridement before being given itraconazole. One patient (case 18) healed without treatment, and in 1 case the treatment is unknown (case 2). Despite the limited number of cases, itraconazole seems to be the most effective treatment. Fluconazole showed high efficacy as well; however, in 2 cases, treatment had to be switched to itraconazole as the final treatment. In our patient, surgical debridement in combination with a prolonged therapy with itraconazole was very effective in clearing the lesions within 6 months (Fig. 3).

Conclusion

PCC is a rare primary infection limited to the skin which can heal without further systemic dissemination in individuals with a competent immune system. Based on our experience and the reviewed cases, itraconazole seems to be the most effective treatment.

Statement of Ethics

The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The patient has given written informed consent for the publication of this case report (including images).

Conflict of Interest Statement

The authors have no conflicts of interest to declare.

Funding Sources

This case report did not receive funding from third parties.

Author Contributions

All authors have made substantial contributions to all of the following: (1) the conception and design of the review and the analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be submitted.
  27 in total

1.  Primary cutaneous cryptococcosis in immunocompetent hosts.

Authors:  A Spiliopoulou; E D Anastassiou; M Christofidou
Journal:  Mycoses       Date:  2012-03       Impact factor: 4.377

2.  EUCAST breakpoints for antifungals.

Authors:  Juan L Rodríguez-Tudela; Maiken C Arendrup; Manuel Cuenca-Estrella; J Peter Donnelly; Cornelia Lass-Flörl
Journal:  Drug News Perspect       Date:  2010-03

3.  Cutaneous cryptococcosis in an immunocompetent host.

Authors:  Sayuri Yuge; Ivander Bastazini Júnior; Maria Carolina Melo Coelho; Cleverson Teixeira Soares
Journal:  Acta Derm Venereol       Date:  2006       Impact factor: 4.437

4.  Primary cutaneous cryptococcosis in an immunocompetent Iraq War veteran.

Authors:  James V Twede; Kristopher M Peters
Journal:  Cutis       Date:  2018-11

5.  Fine-needle aspiration diagnosis of primary cutaneous cryptococcosis in an immunocompetent patient: a case report.

Authors:  Yusef M Al-Marzooq; Rajan Chopra; Mohammad I Al-Mommatten; Mohammad Younis; Abdulrahman S Al-Mulhim; Hassa Al-Hussini
Journal:  Diagn Cytopathol       Date:  2005-04       Impact factor: 1.582

6.  Primary cutaneous cryptococcosis in an immunocompetent host.

Authors:  Monica Pau; Cesarina Lallai; Natalia Aste; Nicola Aste; Laura Atzori
Journal:  Mycoses       Date:  2009-03-14       Impact factor: 4.377

7.  Primary cutaneous cryptococcosis of the penis.

Authors:  Basilio Narváez-Moreno; José Bernabeu-Wittel; Teresa Zulueta-Dorado; Julián Conejo-Mir; Eduardo Lissen
Journal:  Sex Transm Dis       Date:  2012-10       Impact factor: 2.830

Review 8.  Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts.

Authors:  John C Christianson; William Engber; David Andes
Journal:  Med Mycol       Date:  2003-06       Impact factor: 4.076

9.  MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.

Authors:  Carolina Firacative; Luciana Trilles; Wieland Meyer
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

10.  Primary cutaneous cryptococcosis in an elderly pigeon breeder.

Authors:  Meghan Beatson; Michael Harwood; Vail Reese; Leslie Robinson-Bostom
Journal:  JAAD Case Rep       Date:  2019-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.